Vimarsana
Biggest News Aggregation in the World

Page 8 - Shanda Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shanda Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shanda Group Today - Breaking & Trending Today

Synchron Secures $40M in Series B led by Khosla Ventures to Launch U.S. Clinical Trials of Minimally Invasive Brain Computer Interface - Vimarsana News

Synchron Secures $40M in Series B led by Khosla Ventures to Launch U.S. Clinical Trials of Minimally Invasive Brain Computer Interface

Synchron’s flagship StentrodeTM endovascular implant does not require open brain surgery and has obtained FDA Breakthrough Device Designation for the treatment of paralysisThe New York based company is already conducting human trials in Australia and is expected to commence a U.S. clinical trial in 2021NEW YORK--(BUSINESS WIRE)--Synchron, a brain interface platform company,

Turn Biotechnologies completes latest round of funding - Vimarsana News

Turn Biotechnologies completes latest round of funding

Turn Biotechnologies completes latest round of funding Silicon Valley investor Khosla Ventures joins esteemed group of global investors backing Turn MOUNTAIN VIEW, Calif., April 28, 2021 /PRNewswire/ -- Turn Biotechnologies, a company developing novel RNA medicines for untreatable age-related conditions, today announced that it has closed its latest round of funding. The company has the support of investors focused on identifying and backing enterprises that have the potential to change the world with their disruptive technologies. Khosla Ventures, with a history of investing in "Black Swan"...

Chinese Billionaire Chen Tianqiao's Top 10 Stock Picks - Vimarsana News

Chinese Billionaire Chen Tianqiao's Top 10 Stock Picks

Chinese Billionaire Chen Tianqiao’s Top 10 Stock Picks           In this article, we will examine Chinese billionaire Chen Tianqiao’s corporate and investment career. We will also review billionaire Chen Tianqiao’s top 10 stock picks for 2021. You can skip ahead to see Billionaire Chen Tianqiao’s Top 5 Stock Picks. Born in the Chinese province Zhejiang in 1973, the billionaire and online gaming pioneer Chen Tianqiao‘s investment philosophy includes investing primarily in undervalued publicly listed companies with significant turnaround potential. Chen also invests heavily ...

Hustle Fund hits $33.6m final close of second global pre-seed fund - Vimarsana News

Hustle Fund hits $33.6m final close of second global pre-seed fund

Hustle Fund hits $33.6m final close of second global pre-seed fund February 23, 2021 Singapore- and Silicon Valley-based seed investor Hustle Fund has raised $33.6 million for the final close of its second global pre-seed fund. Hustle Fund 2’s anchor limited partners are US venture capital firm Foundry Group Next, Taiwanese corporate Far Eastern Group, Japanese corporate venture arm LINE Ventures, and Chinese private investment firm Shanda Group. Both LINE Ventures and Shanda Group re-joined this vehicle, having anchored Hustle’s $11.5 million debut fund in 2019. Hustle Fund targets the p...

Turn Biotechnologies Expands the Potential of its mRNA Platform by Licensing Unique Artificial Niche Technology - Vimarsana News

Turn Biotechnologies Expands the Potential of its mRNA Platform by Licensing Unique Artificial Niche Technology

Turn Biotechnologies Expands the Potential of its mRNA Platform by Licensing Unique Artificial Niche Technology Niche tech unlocks the power of Turn science for other parts of body News provided by Share this article Share this article MOUNTAIN VIEW, Calif., Feb. 3, 2021 /PRNewswire/ -- Turn Biotechnologies, a company developing medicines for currently untreatable age-related conditions, announced that it has acquired the global rights for new artificial niche (AN) technology that can be used to restore muscle stem cells damaged by aging. The artificial niche replicates the environment of mu...